ClearBridge Investments
BIO icon

ClearBridge Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

ClearBridge Investments’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-104,668
Closed -$59.8M – 828
2021
Q1 		$59.8M Sell
104,668
-7,631
-7% -$4.52M 0.04% 324
2020
Q4 		$65.5M Sell
112,299
-17,096
-13% -$9.74M 0.05% 290
2020
Q3 		$66.7M Sell
129,395
-11,203
-8% -$5.67M 0.06% 245
2020
Q2 		$63.5M Sell
140,598
-39,157
-22% -$17.3M 0.06% 241
2020
Q1 		$63M Buy
179,755
+2,999
+2% +$1.1M 0.07% 216
2019
Q4 		$65.8M Sell
176,756
-1,361
-0.8% -$480K 0.05% 272
2019
Q3 		$59.3M Sell
178,117
-826
-0.5% -$269K 0.05% 286
2019
Q2 		$55.9M Buy
178,943
+4,499
+3% +$1.35M 0.05% 297
2019
Q1 		$53.3M Buy
174,444
+13,735
+9% +$3.71M 0.05% 299
2018
Q4 		$37.3M Buy
160,709
+3,496
+2% +$938K 0.04% 339
2018
Q3 		$49.2M Sell
157,213
-2,728
-2% -$847K 0.04% 329
2018
Q2 		$46.1M Buy
159,941
+34,054
+27% +$9.4M 0.04% 332
2018
Q1 		$31.5M Buy
+125,887
New +$32.1M 0.03% 367

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments's BIO Position: Q2 2021 in Review

ClearBridge Investments sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2021, closing a stake of 104,668 shares — an estimated $59.8M sold.

ClearBridge Investments first reported a position in BIO in Q1 2018 and held it in 13 quarters. The position peaked at $66.7M in Q3 2020. 509 funds tracked by Wall St. Rank hold BIO as of Q2 2021.

  • ClearBridge Investments reported no remaining Bio-Rad Laboratories Class A position as of Q2 2021 after selling out during the quarter.
  • ClearBridge Investments sold 104,668 Bio-Rad Laboratories Class A shares in Q2 2021, an estimated $59.8M.
  • ClearBridge Investments first reported a position in Bio-Rad Laboratories Class A in Q1 2018 and held it in 13 quarters.
  • ClearBridge Investments's Bio-Rad Laboratories Class A position peaked at $66.7M in Q3 2020.
  • 509 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2021.

Based on ClearBridge Investments's 13F filing for Q2 2021, filed 13 Aug 2021.